๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
Trackers Drugs Comparisons API
Trackers› Clinical trials› Dublin
Clinical trial register · Ireland

Clinical Trials in Dublin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 614 matching records held by the registry are in this view. Synced 25 Sep 2026, 03:15 UTC
614
Studies in scope
all four open statuses
320
Recruiting now
open to new participants
179
Lead sponsors
across recruiting studies
7
Irish site locations
across all listed studies
Phase mix of the 320 recruiting studies
Phase 3 96 Not applicable 79 Observational 76 Phase 2 29 Phase 1/2 20 Other 20
Narrow the register Reset
Matches title, registry number, sponsor, intervention and condition.
Recruitment status
Phase
Target enrolment
to

Trials with a site in Dublin

10 of 614 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Irish sites
Start
Recruiting
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ยฑ Obinutuzumab
NCT07024706 Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
AstraZeneca
Phase 2
80
Dublin
2026-06-04
Recruiting
Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT07402915 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal
AstraZeneca
Phase 1
24
Dublin
2026-01-26
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
NCT06868277 Carcinoma, Non-Small Cell Lung
AstraZeneca
Phase 3
830
Cork, Dublin, Galway
2025-04-10
Active, closed
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
NCT05952557 Breast Cancer, Early Breast Cancer
AstraZeneca
Phase 3
5,511
Cork, Dublin, Galway, Waterford
2023-10-05
Recruiting
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
NCT05061550 Non-small Cell Lung Cancer
AstraZeneca
Phase 2
630
Dublin, Galway
2022-04-14
Active, closed
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
NCT03330847 Metastatic Triple Negative Breast Cancer
AstraZeneca
Phase 2
273
Cork, Dublin
2018-03-07
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site, filtered. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-ireland/city/dublin

Query this register directly
GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Ireland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 614 studies in total at the last sync on 25 Sep 2026, 03:15 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Dublin that also match the filters currently applied.

How many clinical trials are recruiting in Dublin?

6 of the 10 studies on this page are recruiting new participants as of the 25 Sep 2026, 03:15 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Dublin), 10 studies
PhaseStudiesRecruitingShare
Phase 36360%
Phase 23230%
Phase 11110%

Most active sponsors

Lead sponsors with the most studies (Dublin)
Lead sponsorStudiesRecruiting
AstraZeneca106
Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.